XML 99 R95.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantor Non-Guarantor Subsidiary Financial Information Level 4 (Details) - Consolidating Statement of Cash Flows (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Net cash provided by (used in) operating activities $ 177 $ 171 $ 51
Cash flows provided by (used in) investing activities      
Capital expenditures (133) (139) (119)
Proceeds from the sale of (purchases of) debt securities, net 2 (2) 4
Change in restricted cash (15) 3 2
Deconsolidation of Variable Interest Entity 0 0 4
Funds remitted to unconsolidated affiliates (3) (4) (1)
Proceeds from sale of assets 11 3 14
Proceeds from sale of business, net of cash transferred 0 173 0
Net cash (used in) provided by investing activities (138) 33 (105)
Cash flows (used in) provided by financing activities      
Net short-term debt (repayments) borrowings (7) 14 (7)
Borrowings of long-term debt 453 496 2,356
Repayments of long-term debt (487) (538) (2,177)
Repayment of advance from affiliates (2) 0 (3)
Repayment of advance from affiliates (7) (100) 0
Capital contribution from parent 16 189 0
Long-term debt and credit facility financing fees (14) (2) (72)
Common stock dividends paid (11) (2) 0
Net cash used in financing activities (59) 57 97
Effect of exchange rates on cash and cash equivalents 5 (5) 2
Decrease in cash and cash equivalents (15) 256 45
Cash and cash equivalents (unrestricted) at beginning of period 416 160 115
Cash and cash equivalents (unrestricted) at end of period 401 416 160
Momentive Specialty Chemicals Inc. [Member]
     
Net cash provided by (used in) operating activities 88 (41) (444)
Cash flows provided by (used in) investing activities      
Capital expenditures (57) (74) (52)
Capitalized Interest   (1) 0
Proceeds from the sale of (purchases of) debt securities, net 0 0  
Change in restricted cash 0 0 0
Deconsolidation of Variable Interest Entity     0
Funds remitted to unconsolidated affiliates 0 0 0
Proceeds from sale of assets 9 2 6
Investments in Marketable Securities     0
Capital contribution to subsidiary (30) (11)  
Proceeds from sale of business, net of cash transferred   49  
Return of capital from subsidiary   47  
Return of capital from subsidiary from sales of accounts receivable 87 69 367
Net cash (used in) provided by investing activities 9 81 321
Cash flows (used in) provided by financing activities      
Net short-term debt (repayments) borrowings 0 (7) 3
Borrowings of long-term debt 0 164 290
Repayments of long-term debt (278) (182) (1,108)
Repayment of advance from affiliates (2) (80) (3)
Repayment of advance from affiliates (7)    
Net Intercompany Loan Borrowings (Repayments) 251 51 987
Long Term Debt and Credit Facility Financing Fees     (9)
Capital contribution from parent 16 189  
Long-term debt and credit facility financing fees (2) (2)  
Common stock dividends paid (11) (2) 0
Return of capital to parent   0  
Return of capital to parent from sales of accounts receivable 0 0 0
Net cash used in financing activities (33) 131 160
Effect of exchange rates on cash and cash equivalents 0 0 0
Decrease in cash and cash equivalents 64 171 37
Cash and cash equivalents (unrestricted) at beginning of period 212 41 4
Cash and cash equivalents (unrestricted) at end of period 276 212 41
Subsidiary Issuers [Member]
     
Net cash provided by (used in) operating activities (59) 8 19
Cash flows provided by (used in) investing activities      
Capital expenditures 0 0 0
Capitalized Interest   0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0  
Change in restricted cash 0 0 0
Deconsolidation of Variable Interest Entity     0
Funds remitted to unconsolidated affiliates 0 0 0
Proceeds from sale of assets 0 0 0
Investments in Marketable Securities     0
Capital contribution to subsidiary 0 0  
Proceeds from sale of business, net of cash transferred   0  
Return of capital from subsidiary   0  
Return of capital from subsidiary from sales of accounts receivable 0 0 0
Net cash (used in) provided by investing activities 0 0 0
Cash flows (used in) provided by financing activities      
Net short-term debt (repayments) borrowings 0 0 0
Borrowings of long-term debt 450 0 1,433
Repayments of long-term debt 0 0 (406)
Repayment of advance from affiliates 0 0 0
Repayment of advance from affiliates 0    
Net Intercompany Loan Borrowings (Repayments) (364) 4 (973)
Long Term Debt and Credit Facility Financing Fees     (63)
Capital contribution from parent 0 0  
Long-term debt and credit facility financing fees (12) 0  
Common stock dividends paid (15) (12) (10)
Return of capital to parent   0  
Return of capital to parent from sales of accounts receivable 0 0 0
Net cash used in financing activities 59 (8) (19)
Effect of exchange rates on cash and cash equivalents 0 0 0
Decrease in cash and cash equivalents 0 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0 0
Combined Subsidiary Guarantors [Member]
     
Net cash provided by (used in) operating activities 16 31 5
Cash flows provided by (used in) investing activities      
Capital expenditures 0 0 0
Capitalized Interest   0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0  
Change in restricted cash 0 0 0
Deconsolidation of Variable Interest Entity     0
Funds remitted to unconsolidated affiliates 0 0 0
Proceeds from sale of assets 0 0 0
Investments in Marketable Securities     0
Capital contribution to subsidiary (19) (19)  
Proceeds from sale of business, net of cash transferred   0  
Return of capital from subsidiary   0  
Return of capital from subsidiary from sales of accounts receivable 0 0 0
Net cash (used in) provided by investing activities (19) (19) 0
Cash flows (used in) provided by financing activities      
Net short-term debt (repayments) borrowings 0 0 0
Borrowings of long-term debt 0 0 0
Repayments of long-term debt 0 0 0
Repayment of advance from affiliates 0 0 0
Repayment of advance from affiliates 0    
Net Intercompany Loan Borrowings (Repayments) (3) 0 0
Long Term Debt and Credit Facility Financing Fees     0
Capital contribution from parent 19 0  
Long-term debt and credit facility financing fees 0 0  
Common stock dividends paid (13) (12) (5)
Return of capital to parent   0  
Return of capital to parent from sales of accounts receivable 0 0 0
Net cash used in financing activities 3 (12) (5)
Effect of exchange rates on cash and cash equivalents 0 0 0
Decrease in cash and cash equivalents 0 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0 0
Combined Non-Guarantor Subsidiaries [Member]
     
Net cash provided by (used in) operating activities 160 198 490
Cash flows provided by (used in) investing activities      
Capital expenditures (76) (65) (67)
Capitalized Interest   0 (1)
Proceeds from the sale of (purchases of) debt securities, net 2 (2)  
Change in restricted cash (15) 3 (2)
Deconsolidation of Variable Interest Entity     4
Funds remitted to unconsolidated affiliates (3) (4) (1)
Proceeds from sale of assets 2 1 8
Investments in Marketable Securities     4
Capital contribution to subsidiary 0 0  
Proceeds from sale of business, net of cash transferred   124  
Return of capital from subsidiary   0  
Return of capital from subsidiary from sales of accounts receivable 0 0 0
Net cash (used in) provided by investing activities (90) 57 (59)
Cash flows (used in) provided by financing activities      
Net short-term debt (repayments) borrowings (7) 21 (10)
Borrowings of long-term debt 3 332 633
Repayments of long-term debt (209) (356) (663)
Repayment of advance from affiliates 0 (20) 0
Repayment of advance from affiliates 0    
Net Intercompany Loan Borrowings (Repayments) 116 (55) (14)
Long Term Debt and Credit Facility Financing Fees     0
Capital contribution from parent 30 30  
Long-term debt and credit facility financing fees 0 0  
Common stock dividends paid 0 (1) (4)
Return of capital to parent   (47)  
Return of capital to parent from sales of accounts receivable (87) (69) (367)
Net cash used in financing activities (154) (165) (425)
Effect of exchange rates on cash and cash equivalents 5 (5) 2
Decrease in cash and cash equivalents (79) 85 8
Cash and cash equivalents (unrestricted) at beginning of period 204 119 111
Cash and cash equivalents (unrestricted) at end of period 125 204 119
Eliminations [Member]
     
Net cash provided by (used in) operating activities (28) (25) (19)
Cash flows provided by (used in) investing activities      
Capital expenditures 0 0 0
Capitalized Interest   0 0
Proceeds from the sale of (purchases of) debt securities, net 0 0  
Change in restricted cash 0 0 0
Deconsolidation of Variable Interest Entity     0
Funds remitted to unconsolidated affiliates 0 0 0
Proceeds from sale of assets 0 0 0
Investments in Marketable Securities     0
Capital contribution to subsidiary 49 30  
Proceeds from sale of business, net of cash transferred   0  
Return of capital from subsidiary   (47)  
Return of capital from subsidiary from sales of accounts receivable (87) (69) (367)
Net cash (used in) provided by investing activities (38) (86) (367)
Cash flows (used in) provided by financing activities      
Net short-term debt (repayments) borrowings 0 0 0
Borrowings of long-term debt 0 0 0
Repayments of long-term debt 0 0 0
Repayment of advance from affiliates 0 0 0
Repayment of advance from affiliates 0    
Net Intercompany Loan Borrowings (Repayments) 0 0 0
Long Term Debt and Credit Facility Financing Fees     0
Capital contribution from parent (49) (30)  
Long-term debt and credit facility financing fees 0 0  
Common stock dividends paid 28 25 19
Return of capital to parent   47  
Return of capital to parent from sales of accounts receivable 87 69 367
Net cash used in financing activities 66 111 386
Effect of exchange rates on cash and cash equivalents 0 0 0
Decrease in cash and cash equivalents 0 0 0
Cash and cash equivalents (unrestricted) at beginning of period 0 0 0
Cash and cash equivalents (unrestricted) at end of period 0 0 0
Consolidated [Member]
     
Net cash provided by (used in) operating activities 177 171 51
Cash flows provided by (used in) investing activities      
Capital expenditures (133) (139) (119)
Capitalized Interest   (1) (1)
Proceeds from the sale of (purchases of) debt securities, net 2 (2)  
Change in restricted cash (15) 3 (2)
Deconsolidation of Variable Interest Entity     4
Funds remitted to unconsolidated affiliates (3) (4) (1)
Proceeds from sale of assets 11 3 14
Investments in Marketable Securities     4
Capital contribution to subsidiary 0 0  
Proceeds from sale of business, net of cash transferred   173  
Return of capital from subsidiary   0  
Return of capital from subsidiary from sales of accounts receivable 0 0 0
Net cash (used in) provided by investing activities (138) 33 (105)
Cash flows (used in) provided by financing activities      
Net short-term debt (repayments) borrowings (7) 14 (7)
Borrowings of long-term debt 453 496 2,356
Repayments of long-term debt (487) (538) (2,177)
Repayment of advance from affiliates (2) (100) (3)
Repayment of advance from affiliates (7)    
Net Intercompany Loan Borrowings (Repayments) 0 0 0
Long Term Debt and Credit Facility Financing Fees     (72)
Capital contribution from parent 16 189  
Long-term debt and credit facility financing fees (14) (2)  
Common stock dividends paid (11) (2) 0
Return of capital to parent   0  
Return of capital to parent from sales of accounts receivable 0 0 0
Net cash used in financing activities (59) 57 97
Effect of exchange rates on cash and cash equivalents 5 (5) 2
Decrease in cash and cash equivalents (15) 256 45
Cash and cash equivalents (unrestricted) at beginning of period 416 160 115
Cash and cash equivalents (unrestricted) at end of period $ 401 $ 416 $ 160